secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kiromic Biopharma, Inc. (—)
CIK:        0001792581
Form:       8-K
Filed at:   2023-12-15T23:59:59+00:00
Accession:  0001558370-23-019843
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiromic BioPharma issues $2M 25% senior secured convertible note
----------------------------------------------------------------

- Principal $2M, interest 25% (27% on default), matures Dec 12, 2024.
- Convertible at $2.50/share; beneficial ownership limitation of 9.99%.
- Secured by all fixtures, equipment, and intellectual property of the company.
- Senior to subordinated debt and equity; company may incur additional senior/pari/junior debt.
- Issued in private placement under Section 4(a)(2) of Securities Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1792581/000155837023019843/0001558370-23-019843-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1792581/000155837023019843/krbp-20231212x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-019843

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer